Compare OABI & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OABI | FSTR |
|---|---|---|
| Founded | 2012 | 1902 |
| Country | United States | United States |
| Employees | 114 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.4M | 280.8M |
| IPO Year | N/A | 1995 |
| Metric | OABI | FSTR |
|---|---|---|
| Price | $1.70 | $28.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $6.67 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 272.5K | 19.3K |
| Earning Date | 03-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $540,009,000.00 |
| Revenue This Year | $52.42 | $5.44 |
| Revenue Next Year | $64.69 | $3.05 |
| P/E Ratio | ★ N/A | $40.75 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $1.22 | $17.16 |
| 52 Week High | $2.49 | $32.63 |
| Indicator | OABI | FSTR |
|---|---|---|
| Relative Strength Index (RSI) | 40.09 | 39.50 |
| Support Level | $1.51 | $27.26 |
| Resistance Level | $1.75 | $29.72 |
| Average True Range (ATR) | 0.12 | 1.17 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 5.13 | 28.74 |
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.